Cancer Targeted Gene Panel Colon Colorectal Test
Comprehensive Genetic Analysis for Colorectal Cancer
The Cancer Targeted Gene Panel Colon Colorectal Test represents a cutting-edge molecular diagnostic approach that provides comprehensive genetic profiling for colorectal cancer patients. This advanced testing methodology utilizes next-generation sequencing (NGS) technology to analyze critical genetic markers that influence treatment decisions and disease management strategies.
What This Test Measures and Detects
Our comprehensive panel evaluates multiple essential genetic biomarkers:
- Microsatellite Instability (MSI) Panel: Assesses DNA mismatch repair status, crucial for immunotherapy eligibility
- KRAS Mutations: Identifies specific mutations that predict resistance to EGFR-targeted therapies
- BRAF Mutations: Detects V600E and other mutations with prognostic and therapeutic implications
- PIK3CA Mutations: Evaluates mutations in the PI3K pathway affecting treatment response
- PTEN Analysis: Assesses tumor suppressor gene status influencing multiple signaling pathways
Who Should Consider This Test
This comprehensive genetic panel is recommended for individuals experiencing:
- Newly diagnosed colorectal cancer requiring treatment planning
- Recurrent or metastatic colorectal cancer needing targeted therapy options
- Family history of colorectal cancer or hereditary cancer syndromes
- Unusual tumor characteristics or treatment-resistant disease
- Need for immunotherapy eligibility assessment
- Planning for personalized treatment strategies
Key Benefits of Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages:
- Personalized Treatment Selection: Identifies the most effective targeted therapies based on your tumor’s genetic profile
- Immunotherapy Guidance: Determines eligibility for immune checkpoint inhibitors through MSI status
- Prognostic Information: Provides insights into disease behavior and potential outcomes
- Clinical Trial Matching: Opens opportunities for targeted clinical trials based on genetic markers
- Family Risk Assessment: Helps identify hereditary cancer syndromes affecting family members
- Treatment Optimization: Avoids ineffective therapies and potential side effects
Understanding Your Test Results
Your comprehensive genetic report will include detailed information about:
- Mutation Status: Clear identification of detected genetic alterations in each tested gene
- Clinical Significance: Interpretation of how each finding impacts treatment options
- Therapeutic Implications: Specific recommendations for targeted therapies based on results
- MSI Status: Classification as microsatellite stable (MSS) or unstable (MSI-H)
- Actionable Findings: Clear guidance on next steps and treatment considerations
Your oncologist will review these results with you to develop a personalized treatment plan tailored to your specific genetic profile.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $676 |
Nationwide Accessibility
We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our nationwide network ensures that advanced genetic testing is accessible to patients regardless of location.
Take Control of Your Cancer Journey
Understanding your tumor’s genetic makeup is the first step toward personalized cancer care. Our comprehensive Cancer Targeted Gene Panel provides the critical information needed to make informed treatment decisions and optimize your therapeutic approach.
Ready to gain insights into your colorectal cancer treatment options? Call our dedicated genetic counseling team at +1(267) 388-9828 or book your test online today. Our specialists are available to answer your questions and guide you through the testing process.
Turnaround Time: Sample collected by Tuesday 9 AM; Results delivered within 10 working days
Sample Requirements: Formalin fixed paraffin embedded tissue block with minimum 10% tumor content
Mandatory: Completed NGS Test Requisition Form (Form 40)
